Roadrunner Extra Support Wire Guide
K183467 · Cook Incorporated · DQX · Jan 11, 2019 · Cardiovascular
Device Facts
| Record ID | K183467 |
| Device Name | Roadrunner Extra Support Wire Guide |
| Applicant | Cook Incorporated |
| Product Code | DQX · Cardiovascular |
| Decision Date | Jan 11, 2019 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 870.1330 |
| Device Class | Class 2 |
Intended Use
The Roadrunner Extra Support Wire Guide is intended for use in facilitating delivery of percutaneous catheters into the cardiovascular system.
Device Story
Roadrunner Extra Support Wire Guide is a sterile, single-use catheter guide wire used to facilitate percutaneous catheter delivery within the cardiovascular system. The device consists of a coated mandril with a coil covering the tip, which is formed into an angled configuration. A pin vise is included. The device is operated by a physician in a clinical setting to navigate the vasculature. By providing a track for catheter advancement, the wire guide assists in reaching target anatomical sites, potentially improving procedural efficiency and patient outcomes. The subject device is a modification of the predicate, offering an 0.018-inch outer diameter and lengths of 180, 270, and 300 cm.
Clinical Evidence
Bench testing only. Testing performed in accordance with BS EN ISO 11070:2014 (corrosion, flex, fracture, tensile, flex on aged devices) and FDA Coronary and Cerebrovascular Guidewire Guidance (1995) (surface condition, rotational response, torque strength, compatibility, dimensional analysis). Radiopacity evaluated per ASTM F640-12. All pre-determined acceptance criteria were met.
Technological Characteristics
Coated mandril with coil-covered tip; angled tip configuration. Outer diameter: 0.018 inch. Lengths: 180, 270, 300 cm. Sterile, single-use. Testing standards: BS EN ISO 11070:2014 (corrosion, flex, fracture, tensile), ASTM F640-12 (radiopacity).
Indications for Use
Indicated for patients requiring percutaneous catheter delivery into the cardiovascular system.
Regulatory Classification
Identification
A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.
Special Controls
*Classification.* Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
Predicate Devices
- Roadrunner Extra Support Wire Guide (K171948)
Related Devices
- K171948 — Roadrunner Extra Support Wire Guide · Cook Incorporated · Jan 5, 2018
- K182985 — Roadrunner PC Wire Guide, Olcott Torque Device · Cook Incorporated · Jul 22, 2019
- K982876 — HI-TORQUE STEELCORE 18 GUIDE WIRE MODEL NUMBERS 1003280, 1003281, 1003282 · Guidant Corp. · Nov 10, 1998
- K171912 — Double Flexible Tip Wire Guides · Cook Incorporated · Mar 19, 2018
- K260537 — Willow 24 Guidewire · Arbor Endovascular, LLC · Mar 19, 2026
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
January 11, 2018
Cook Incorporated Daniel Corbin Regulatory Affairs Specialist 750 Daniels Way Bloomington, Indiana 47404
Re: K183467
Trade/Device Name: Roadrunner Extra Support Wire Guide Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: DOX Dated: December 13, 2018 Received: December 14, 2018
Dear Daniel Corbin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
{1}------------------------------------------------
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
# Michael John -S 2019.01.11 15:18:36 -05'00'
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known) K183467
#### Device Name
Roadrunner® Extra Support Wire Guide
Indications for Use (Describe)
The Roadrunner Extra Support Wire Guide is intended for use in facilitating delivery of percutaneous catheters into the cardiovascular system.
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
K183467
Image /page/3/Picture/1 description: The image contains the logo for Cook Medical. The logo consists of the word "COOK" in large, white, sans-serif font, positioned above the word "MEDICAL" in a smaller, white, sans-serif font. Both words are set against a red background. The word "MEDICAL" is placed on a rectangular shape that is slightly offset from the main red background, creating a layered effect.
### 510(k) SUMMARY
## Submitted By:
Daniel J. Corbin Cook Incorporated 750 Daniels Way P.O. Box 489 Bloomington, IN 47402 Phone: (812) 335-3575 x104018 Fax: (812) 332-0281 Date Prepared: December 13, 2018
COOK INCORPORATED 50 DANIELS WAY, P.O. BOX 489
WW.COOKMEDICAL.CO
#### Device:
Trade Name: Common Name: Classification Name:
Roadrunner® Extra Support Wire Guide Wire, Guide, Catheter Catheter guide wire DQX (21 CFR §870.1330)
#### Indications for Use:
The Roadrunner® Extra Support Wire Guide is intended for use in facilitating delivery of percutaneous catheters into the cardiovascular system.
#### Predicate Device:
The device, subject of this submission, is substantially equivalent to the predicate device, the Roadrunner® Extra Support Wire Guide, cleared under 510(k) number K171948.
## Comparison to Predicate Device:
It has been demonstrated that the subject device, Roadrunner® Extra Support Wire Guide, is a modification to the predicate device. The subject device, Roadrunner® Extra Support Wire Guide is identical in terms of intended use, principles of operation, materials of construction, and basic technological characteristics to the predicate device. The predicate device, K171948, is available with an outer diameter of 0.014 inch and lengths of 180 and 300 centimeters and the subject device, the Roadrunner® Extra Support Wire Guide, is available with an outer diameter of 0.018 inch and lengths of 180, 270, and 300 centimeters.
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the logo for Cook Medical. The logo consists of the word "COOK" in large, white, sans-serif font on a red background. Below the word "COOK" is the word "MEDICAL" in a smaller, white, sans-serif font on a red background.
COOK INCORPORATED
750 DANIELS WAY, P.O. BOX 489
BLOOMINGTON, IN 47402-0489 U.S.A.
PHONE: 812.339.2235 TOLL FREE: 800.457.4500
WWW.COOKMEDICAL.COM
# Device Description:
The Roadrunner® Extra Support Wire Guide is manufactured in an outer diameter of 0.018 inch and lengths of 180, 270, and 300 centimeters. The flexible tip portion of the subject device is formed into an angled configuration. The Roadrunner® Extra Support Wire Guide consists of a coated mandril with a coil covering the tip of the mandril. A pin vise is supplied with the subject device.
The Roadrunner® Extra Support Wire Guide is a packaged, sterile device intended for single use.
## Test Data:
The following tests were performed to demonstrate that the Roadrunner® Extra Support Wire Guide met applicable design and performance requirements and support a determination of substantial equivalence.
- I Immersion Corrosion Testing - Testing demonstrated, when tested in accordance with Annex B of BS EN ISO 11070:2014, the device revealed no signs of corrosion that would affect functional performance. The pre-determined acceptance criteria were met.
- Surface Condition/Analysis Testing – Characterization testing was performed in accordance with the FDA Coronary and Cerebrovascular Guidewire Guidance (1995).
- Flex Testing – Testing was performed in accordance with Annex G of BS EN ISO 11070:2014. The pre-determined acceptance criteria were met.
- . Fracture Testing – Testing was performed in accordance with Annex F of BS EN ISO 11070:2014. The pre-determined acceptance criteria were met.
- Tensile Testing Testing was performed in accordance with Annex H of BS EN ISO . 11070:2014. The pre-determined acceptance criteria were met.
- . Radiopacity Testing - Radiopacity testing was performed in accordance with the qualitative evaluation described in ASTM F640-12.
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for Cook Medical. The logo is set against a red background. The word "COOK" is written in large, white, sans-serif letters. Below "COOK" is a smaller rectangle, also in red, with the word "MEDICAL" written in white, sans-serif letters.
- Rotational Response (Torqueability) Testing - Characterization testing was performed in accordance with the FDA Coronary and Cerebrovascular Guidewire Guidance (1995).
- . Torque Strength Testing - Characterization testing was performed in accordance with the FDA Coronary and Cerebrovascular Guidewire Guidance (1995).
- Compatibility Testing Testing was performed in accordance with the FDA . Guidance for Coronary and Cerebrovascular Guidewires (1995). The pre-determined acceptance criteria were met.
- Dimensional Analysis Testing Testing was performed in accordance with the FDA . Coronary and Cerebrovascular Guidewire Guidance (1995). The pre-determined acceptance criteria were met.
- . Flex Testing on Aged Devices – Flex testing was performed on aged devices in accordance with Section 8.5 and Annex B of BS EN ISO 11070:2014. The predetermined acceptance criteria were met.
In conclusion, the results of these tests support a determination of substantial equivalence to the predicate device.